BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 20382723)

  • 1. Daptomycin in synovial fluid during treatment of methicillin-resistant Staphylococcus aureus septic arthritis.
    Ritchie ND; Lovering AM; Seaton RA
    J Antimicrob Chemother; 2010 Jun; 65(6):1314-5. PubMed ID: 20382723
    [No Abstract]   [Full Text] [Related]  

  • 2. How common is MRSA in adult septic arthritis?
    Frazee BW; Fee C; Lambert L
    Ann Emerg Med; 2009 Nov; 54(5):695-700. PubMed ID: 19665261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia.
    Jacobson LM; Milstone AM; Zenilman J; Carroll KC; Arav-Boger R
    Pediatr Infect Dis J; 2009 May; 28(5):445-7. PubMed ID: 19295462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of adequate intravitreal concentrations of daptomycin after systemic intravenous administration in a patient with endogenous endophthalmitis.
    Sheridan KR; Potoski BA; Shields RK; Nau GJ
    Pharmacotherapy; 2010 Dec; 30(12):1247-51. PubMed ID: 21114392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable daptomycin susceptibility in patients receiving intravenous vancomycin for meticillin-resistant Staphylococcus aureus infections.
    Golden M; Shaib W; Havill N
    Int J Antimicrob Agents; 2010 Mar; 35(3):306-8. PubMed ID: 20036108
    [No Abstract]   [Full Text] [Related]  

  • 6. Causative Pathogens, Antibiotic Susceptibility, and Characteristics of Patients with Bacterial Septic Arthritis over Time.
    Jinno S; Sulis CA; Dubreuil MD
    J Rheumatol; 2018 May; 45(5):725-726. PubMed ID: 29717095
    [No Abstract]   [Full Text] [Related]  

  • 7. Hip pain and fever: when it's not a septic joint, what's next?
    Leuthauser A; Paul A
    Pediatr Emerg Care; 2015 Jan; 31(1):42-3. PubMed ID: 25560620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRSA joint infection in a psoriatic patient with a coexisting respiratory infection.
    Begkas D; Kouskoukis C; Katsenis D; Schoinochoritis N
    Med Glas (Zenica); 2013 Feb; 10(1):171-3. PubMed ID: 23348186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model.
    Dandekar PK; Tessier PR; Williams P; Nightingale CH; Nicolau DP
    J Antimicrob Chemother; 2003 Sep; 52(3):405-11. PubMed ID: 12917254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review: Daptomycin for the treatment of gram-positive infections in neutropenic cancer patients.
    Rolston KV
    Clin Adv Hematol Oncol; 2008 Nov; 6(11):815-7. PubMed ID: 19194365
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of methicillin-resistant staphylococcus aureus meningitis with daptomycin.
    Lee DH; Palermo B; Chowdhury M
    Clin Infect Dis; 2008 Aug; 47(4):588-90. PubMed ID: 18636964
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of daptomycin for Staphylococcus aureus infections in critical care medicine.
    Alder J
    Crit Care Clin; 2008 Apr; 24(2):349-63, ix-x. PubMed ID: 18361950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal bacteraemia caused by daptomycin-non-susceptible, vancomycin-intermediate, meticillin-resistant Staphylococcus aureus in a patient with chronic kidney disease.
    Kuo CC; Wu VC; Huang YT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2009 Jan; 33(1):96-8. PubMed ID: 18790610
    [No Abstract]   [Full Text] [Related]  

  • 14. [Conservative treatment of a hip prosthesis infection due to methicillin-resistant Staphylococcus aureus using prolonged antibiotic therapy based on linezolid followed by daptomycin].
    Grossi O; Talarmin JP; Boutoille D; Frioux R; Corvec S; Raffi F
    Med Mal Infect; 2008 Dec; 38 Spec No 2():10-2. PubMed ID: 19185203
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin.
    Skiest DJ
    J Clin Microbiol; 2006 Feb; 44(2):655-6. PubMed ID: 16455939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term use of daptomycin for MRSA osteomyelitis and joint infection.
    Burns CA
    Scand J Infect Dis; 2008; 40(2):183-6. PubMed ID: 17852899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of multiple lung abscesses during daptomycin treatment for right-sided endocarditis caused by meticillin-resistant Staphylococcus aureus.
    Liu CY; Wang JL; Huang YT; Hsueh PR
    Int J Antimicrob Agents; 2008 Dec; 32(6):544-5. PubMed ID: 18789850
    [No Abstract]   [Full Text] [Related]  

  • 18. [The second life of daptomycin: analysis of a successful come-back].
    Decousser JW; Doucet Populaire F
    Med Mal Infect; 2008 Dec; 38 Spec No 2():1-3. PubMed ID: 19185200
    [No Abstract]   [Full Text] [Related]  

  • 19. Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia.
    Mangili A; Bica I; Snydman DR; Hamer DH
    Clin Infect Dis; 2005 Apr; 40(7):1058-60. PubMed ID: 15825002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of mitral MRSA endocarditis using daptomycin].
    Senneville E; Beltrand E; Legout L; Leroy O; Fayad G
    Med Mal Infect; 2008 Dec; 38 Spec No 2():13-5. PubMed ID: 19185204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.